
Clee Medical
Neurotechnology startup revolutionizing brain treatments with real-time, precise imaging for enhanced surgical outcomes.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
* | CHF120k | Grant | |
Total Funding | 000k |
Related Content
Clee Medical is a neurotechnology startup dedicated to transforming brain treatments through innovative imaging solutions. Operating in the healthcare sector, the company focuses on providing real-time brain visualization technology that enhances precision in neurosurgery. This technology eliminates the need for contrast agents or radiation, offering a safer and more accurate alternative to traditional MRI imaging. Clee Medical's disposable endoscopic probe integrates seamlessly with existing neurosurgical workflows, making it a practical choice for medical professionals. The company's business model revolves around selling these advanced imaging solutions to hospitals and clinics, thereby generating revenue through product sales. By addressing the intraoperative imaging gap, Clee Medical serves neurosurgeons and healthcare institutions seeking to improve surgical precision and patient outcomes. The startup is based in Geneva, Switzerland, and is committed to setting new standards in neuroimaging and targeted neurotherapies. Keywords: neurotechnology, brain treatments, real-time imaging, neurosurgery, precision, endoscopic probe, healthcare, Switzerland, surgical outcomes, intraoperative.